Transcriptional profiling of PBMCs from G2019S LRRK2 PD patients revealed a deregulation in leukocyte extravasation signaling and other immune functions, including an up-regulation of IFN-γ mRNA [40]. This evidence concerns the gene LRRK2 and Parkinson disease.